Prothena Corp. Plc (PRTA)
10.82
-0.36
(-3.22%)
USD |
NASDAQ |
May 07, 11:52
Prothena Free Cash Flow : -168.85M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novo Nordisk A/S | 4.403B |
| Jazz Pharmaceuticals Plc | 1.186B |
| Amarin Corp. Plc | 25.63M |
| Iterum Therapeutics Plc | -19.63M |
| GH Research Plc | -45.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.97M |
| Cash from Investing (Quarterly) | 0.002M |
| Cash from Financing (Quarterly) | 0.0021M |
| Free Cash Flow Per Share (Quarterly) | -0.4081 |
| Free Cash Flow to Equity (Quarterly) | -21.26M |
| Free Cash Flow to Firm (Quarterly) | -21.97M |
| Free Cash Flow Yield | -28.99% |